LUPIN LTD. - 500257 - U.S. FDA Inspection Of The Company'S Biotech Facility In Pune.

Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Mid-range Performer

1910.3000 -22.90 (-1.18%)

NSE Sep 30, 2025 13:44 PM

Volume: 429.2K

Lupin Ltd.

05 Oct 2024

1910.30

-1.18%

Company Update

LUPIN LTD. - 500257 - U.S. FDA Inspection Of The Company'S Biotech Facility In Pune.

BSE India

U.S. FDA Inspection of the Company''s Biotech Facility in Pune.

More from Lupin Ltd.

Recommended

Market trades higher, Hindustan Copper to triple mining capacity by FY31

Trendlyne Marketwatch | 30 Sep 2025, 01:27PM

IPO frenzy continues: 23 companies to list; 21 new issues hit the market this week

| 29 Sep 2025, 04:41PM

Lupin expects normalization by September quarter